Thursday, August 23, 2012

NeoVar, Next Generation Creatine, 110 Capsules, Applied Nutriceuticals @$ 13.80


Applied Nutriceuticals NeoVar


  • Dietary supplement.

  • Next generation creatine for maximum cellular recovery.

  • Recomped. Better results through science.

  • Formulated to mirror your body's naturally occurring intra muscular creatine profile.

  • Increases cellular volume maximizing muscular size and strength while increasing protein synthesis.

  • Maximizes nutrient uptake for superior post-workout/recovery.

Nutrition Facts

Serving Size 1 capsule

Servings Per Container 110

Amount Per Serving 
% Daily Value 

PCr-Mono Matrix (Proprietary Blend) 646 mg 

Glucovar/Adenylate Cyclase Sensitization Complex (Proprietary Blend) 104 mg 



Inactive Ingredients: Gelatin, Candurin Silver Fine, FD&C Red No. 3, FD&C Yellow No. 5, FD&C Blue No. 1.



Directions:

Suggested Dosage: (Take with carbohydrates). Body Weight (lbs.): Up to 150, Divided Doses (2x a day): 2 capsules (4 daily); Body Weight (lbs.): 150-250, Divided Doses (2x a day): 3 capsules (6 daily); Body Weight (lbs.): 250 and up, Divided Doses (2x a day): 4 capsules (8 daily). Take immediately post-workout with carbohydrates, preferably sugars. Take second dose with any other meal throughout the day containing carbohydrates.

Warnings: This product is only intended to be consumed by healthy adults 18 years of age or older. Do not use if you are pregnant or nursing. Before using product, seek advice from a physician if you are unaware of your current health condition or have any pre-existing medical condition including but not limited to kidney disease or if you are taking any prescription or over the counter medication. Do not use if you are pregnant, nursing, prone to dehydration or exposed to excessive heat. Discontinue use and consult your health care professional if you experience any adverse reaction to this product. Before beginning any weight loss program, consult your health care provider.

For more details contact www.vitadigest.com




No comments: